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ABSTRACT
Pre-eclampsia can be a serious development for both mother and fetus during
pregnancy. Increased mortality and morbidity rates have been shown in women
diagnosed with pre-eclampsia. Higher education for registered nurses on a Women’s
Urgent Care (WUC) center will help diagnose the mother more quickly and inevitably
receive treatment sooner leading to better outcomes for the birth of her newborn. The
educational tools used in the study were a pre-and post-test and an educational video for
the registered nurses to watch. A retrospective chart review before and after the
intervention will help to see if there is any decrease in the time of treatment for the
patient.
With the tools used for the project, the post chart reviews indicated a decrease in
compliance from the nurses, an increase in the times between when the patient presented
to WUC and treatment. The times increased also from when nurse gave medication after
getting the increased BP reading. Although the times increased, more education on the
nurses' level and perhaps the providers level to help decrease the mortality rates of
women. Monitoring and giving treatment to the patients when needed is the role of the
registered nurses in a hospital setting. Education helps to keep them up to date on the best
way to care for the patients. Pre-eclampsia is a major concern in a labor and delivery unit
and needs to be addressed due to the increased mortality rate.
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CHAPTER I – INTRODUCTION
Background
The doctoral student was asked to perform education on pre-eclampsia in a
Women’s Urgent Care (WUC) unit to comply with the Joint Commission guidelines of
2020. The Joint Commission was founded in 1951 and works to continuously improve
healthcare establishments by inspiring the organizations to excel in proving safe and
high-quality healthcare (Lyons, 2019). The goal of this research was to measure the
effectiveness of pre-eclampsia education using a pretest, posttest design. To comply with
IRB guidelines for 2020, the doctoral student created an educational video to upload
online for the participants in the study to view.
Significance
Labor and delivery is a specialized area of practice for registered nurses (RN).
The RNs not only care for one patient but two, therefore, the RN should be educated on
pathophysiology of the mother and the baby (Lyons, 2019). When a mother comes in and
is experiencing high blood pressure (BP), she and the baby are affected and at increased
risk for mortality and morbidity by the changes in the maternal system. The Joint
Commission has started a project for maternal patient safety. The Joint Commission has
created six requirements for the hospitals to follow:
1) detailing within the policy and procedure steps for accurately measuring and
remeasuring maternal blood pressure 2) development of a policy and procedure
for managing maternal patients with severe hypertension/preeclampsia 3) delivery
of staff and provider education on maternal hypertension/preeclampsia 4)
conducting OB severe hypertension/preeclampsia drills 5) performing OB severe
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hypertension/preeclampsia case reviews 6) delivery of patient and family
education. (McGolrick, 2020, para. 18-23)
The doctoral student’s goal was to improve outcomes in pre-eclampsia patients by
delivering education to the RNs. The doctoral student plans on educating RNs to assess
their patients and interventions. At the facility where the doctoral student will be
implementing the education, women present to an urgent care center before they are
transferred to the labor and delivery floor. Educating RNs in the outpatient urgent care
center will expedite care by identifying the problem before the patient is transferred to the
labor and delivery unit.
Problem Statement
The Doctor of Nursing Practice (DNP) project PICOT question format is: Among
registered nurses in a woman’s urgent care center (P), will additional education in preeclampsia (I), instead of no continuing education (C), increase awareness (O) after one
10-minute educational video (T).
Available Knowledge
Pre-eclampsia is a condition characterized by an elevated systolic BP above 140
mmHg, an elevated diastolic BP above 90 mmHg along with proteinuria (>300 mg/day)
after 20 weeks gestation. Along with the elevated blood pressure, the pregnant woman
may experience “edema, epigastric pain, blurred vision, and a headache which will not
subside after interventions are taken” (Royani et al., 2019, p. 1). Complications may arise
from pre-eclampsia for the mother as well as the fetus. Maternal complications may
include “cardiovascular disease, cerebral disease, liver and/or renal failure, placental
abruption, seizures, or disseminated intervascular coagulation” (Royani et al., 2019, pp.
2

1-2). Fetal complications include “low birth rate, fetal growth restriction, preterm birth,
severe birth asphyxia, and stillbirth” (Royani et al., 2019, p. 2).
Predicting who will develop pre-eclampsia during pregnancy is difficult due to
the unknown nature of the syndrome, but certain risk factors involved may increase a
woman’s chance. Risk factors include a history of pre-eclampsia in earlier pregnancies,
family history, primigravida, multiple gestation, history of hypertension, diabetes, or
kidney disease, obesity, advanced maternal age, young maternal age, in-vitro fertilization,
African American descent, having an autoimmune disease (Lupus), or polycystic ovarian
syndrome. Research has shown probable causes of pre-eclampsia. Genetic abnormalities,
poor uterus perfusion, and an abnormally functioning placenta are all probable causes of
pre-eclampsia. During pregnancy,
… highly invasive extravillous trophoblasts (EVT) acquire vascular-like
properties to remodel uterine spiral arterioles. This creates low-resistance, largediameter vessels which promote uteroplacental blood supply to sustain fetal
growth. It is widely accepted that inadequate trophoblast invasion and impaired
uterine spiral artery remodeling is an initiating factor in the development of
preeclampsia. (Winship et al., 2015, p. 15928)
Extravillous trophoblasts are what connects the placenta to the uterus wall and control the
opening of the spiral arteries. Researchers conclude that when the spiral arteries are
narrowed is a major cause of pre-eclampsia (Moser et al., 2016). Narrowing of the
arteries impairs the ability for uteroplacental artery perfusion and restricts nutrients and
oxygen to the fetus.

3

The only way to fully treat pre-eclampsia is to deliver the baby and the placenta,
whether by vaginal delivery or cesarean section before the condition turns into eclampsia.
Deciding if the risk outweighs the benefits of delivering the baby is ultimately up to the
physician. Studies have shown Magnesium sulfate is a medication used to prevent
eclampsia in the woman and severely elevated BP’s. Magnesium sulfate is not used to
lower BP, but to prevent seizures. High BP’s, when the systolic BP is above 160 mmHg
and the diastolic BP is above 110 mmHg, intravenous anti-hypertensives such as labetalol
or hydralazine should be used to lower the BP to a safe level. Administration of
intravenous labetalol for severe hypertension guidelines state to give 20mg of intravenous
labetalol and check the BP after 20 minutes. If the BP is still elevated with systolic
pressure at or above 160 and diastolic pressure at or above 110, give 40mg of labetalol
intravenously. If the BP remains elevated after 20 minutes, give 80mg of labetalol
intravenously. The total amount of labetalol given in 24 hours should not exceed 300mg.
If the BP continues to be elevated after giving 80mg of labetalol intravenously, give
10mg of hydralazine intravenously. If the BP remains elevated wait for further orders
from the physician. If the BP is below the threshold, continue to monitor the BP every 10
minutes for an hour, then every 15 minutes for one hour, followed by every 30 minutes
for one hour, and then hourly (American College of Obstetrics and Gynecology [ACOG],
2019).
Needs Assessment
The rates of maternal mortality are rising, the numbers have almost doubled since
1987, reaching the rate of 29.6 maternal deaths per 100,000 live births in the United
States. Maternal mortality numbers include deaths related to or aggravated by pregnancy
4

and the management of the pregnancy (excluding accidental or incidental causes), during
pregnancy or childbirth, or within one year of termination of pregnancy. The number of
29.6 is well above the Healthy People 2020 goal of 11.4. Mississippi has a maternal
mortality rate of 27.2 per 100,000 live births (United Health Foundation [UHF], 2020).
Pre-eclampsia is accountable for 6.8% of pregnancy-related deaths in the United States.
Although a woman has a 5-8% chance of experiencing pre-eclampsia, every patient
should be screened and monitored for early warning signs (McGolrick, 2020). In
Mississippi in the years from 2013-2016, there were 13 deaths associated with
hypertension in pregnancy. Five were pre-eclampsia related and 5 were hypertensionrelated that was either synchronized with or related to hypertension during pregnancy
(Mississippi State Department of Health [MSDH], 2019).

Figure 1. Pre-Eclampsia Rate
Synthesis of Evidence
Search
Five search methods were used: CINAHL with full-text, MEDLINE, PubMed,
Google scholar, and google. The search aimed to locate capacity-building articles in
public health records, evidence-based practice guidelines, pre-and post-test use, the
pathophysiology of the placenta and maternal changes during pregnancy, and general
5

information on learning theories. Phrases were used with the text related to pre-eclampsia
(preeclampsia and pre-eclampsia), maternal mortality (Mississippi and nationwide), joint
commission guidelines preeclampsia, education for registered nurses, continuing
education, reliability and validity in the questionnaire, and transformational learning
(Mezirow’s Theory). Other phrases for the pathophysiology of the placenta and maternal
changes were trophoblasts, placenta attachment, kidney changes with pre-eclampsia,
maternal changes in pre-eclampsia, and causes of pre-eclampsia. Articles were included
if they were government organizations, peer-reviewed, guidelines, and/or healthcarerelated.
Evidence-Based Findings
The cause of pre-eclampsia is unknown, but some theories suggest the reason why
some women will develop the disorder and others do not. Zhang, Ye, and Chen (2013)
state that pre-eclampsia is caused by a poor placenta, and the poor plantation of the
placenta causes hypoxia and oxidative stress. Zhang et al. (2013) also state that evidence
suggests that the maternal immune response and endocrine system cause shallow
implantation. The shallow implantation causes an immune intolerance to pater-derived
fetal antigens. The shallow implantation, in turn, causes inadequate spiral arteries, which
is what connects the placenta to the uterine wall.
Winship et al. (2015) agree that there is poor placenta perfusion that causes preeclampsia, and they state that Interleukin 11 elevation is a major concern. “Interleukin11
(IL11) is a pleiotropic cytokine that regulates cell cycle, invasion, and migration in
numerous cell types, all roles in critical placental development” (Winship et al., 2015, p.
15928). The elevated IL11 is what causes spiral artery remodeling and placentation.
6

Although the only true way to cure pre-eclampsia is to deliver the placenta, some
scientists are saying that antiplatelet therapy can prevent women with high-risk factors
from developing pre-eclampsia. Duley et al. (2019) state that using antiplatelet therapy
can reduce the chance of proteinuric pre-eclampsia by 18%. Administering low-dose
aspirin starting in the first trimester of pregnancy, can reduce the rate of pre-eclampsia,
small for gestational age newborns, preterm births, and fetal death. Although low-dose
aspirin lowered all these conditions, daily low-dose aspirin only slightly raised the chance
of postpartum hemorrhage.
Basic nursing knowledge about critical thinking, patient care, and
pathophysiology of the human body is given during nursing school. Continuing education
after school allows RNs to build on their evidence-based knowledge and critical thinking
skills (Roney & Acri, 2019). Roney and Acri (2019) state that obtaining quality education
can be more difficult for rural nurses due to the financial restraints of having to travel and
they might not have ancillary support like nurses in a more urban setting would have.
Roney and Acri state that online learning has opened the door for nurses to have quality
education no matter their location. The medical field is forever changing, and continuing
education gives nurses the knowledge to give their patients the best, safest care possible.
Employers encourage continuing education for nurses “raised staff morale, increased
motivation and staff retention” and nurses saw continued education beneficial for
“enhancement of professional knowledge; advancing professionally; providing relief
from routine; improvement of social relations; and acquirement of credentials” (Richards
& Potgieter, 2010, p. 43).
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Theoretical Framework
Many theories exist for adult education, ranging from a discussion, and finding
their answers to telling the students what to learn. The Transformational Learning Theory
describes one aspect of adult learning developed by Jack Mezirow in 1991.
Transformational learning focuses on “critical reflection on personal assumptions,
attitudes, and beliefs followed by discourse to understand and validate the new insights”
of the learner (Matthey-Maich et al., 2010, p. 25). Transformational learning goes above
the basic knowledge and focuses on the deeper and more constructive learning and
focuses on the critical aspect of the learner. The doctoral student believes that by
explaining why the recipients should learn the new protocol of treating pre-eclampsia and
educating the participant as to what is happening in the body, the participant will
remember the information better and be able to 1) enforce the education in their own
nursing practice 2) educate the patients as to why the tests are being performed, what preeclampsia is, and why it is taken so seriously by the medical team. “Mezirow's initial
research led him to theorize that adults don’t apply their old understanding to new
situations, instead they find they need to look at new perspectives to get a new
understanding of things as they change” (Western Governor’s University [WGU], 2020,
para. 2). Transformational learning is not memorization, it is a firm understanding and
knowledge base that increases actions and stimulates more critical thinking, and asking
more questions to form more knowledge (Marrocco et al., 2014).
Western Governor’s University (2020) states that there are different phases of
transformative learning:
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1) A disorienting dilemma
2) Self-examination
3) critical assessment of assumptions
4) planning a course of action
5) acquisition of knowledge or skills to carry out a new plan
6) exploring and trying new roles
7) building self-efficacy in new roles and relationships. (WGU, 2020, Phases of
Transformative Leadership section)
The RNs that will be participating in the education will already know the basics
but understand that there is more information that they can always learn, which is part of
transformational learning. The act of learning and applying the new information to the
workplace is steps three to five. By the participants signing up for the research and
educational video, the participant is on steps three and four; step four being that they are
signing up for the video to continue their learning.
The RNs involved in this study have experience in their field of expertise. The
RNs know what to look for and what pre-eclampsia is, but do the RNs have a firm
understanding of what is happening in the body? With this type of education, the doctoral
student is hoping for an “aha” moment where the RNs understand what is happening in
their patients' bodies and they are more aware of the seriousness of the situation and can
remember treatment protocols because the RNs know what they are looking for and why.
Specific Aims
The goal of the study is to measure education on pre-eclampsia in a WUC unit.
After researching the mortality and morbidity maternal rates, not only in Mississippi but
9

the United States, the doctoral student agrees with The Joint Commission. More
education on pre-eclampsia for RNs is needed. The education not only should cover the
correct treatment protocol, but also the pathophysiology to know what signs to look for in
patients that present to the unit and to understand why the provider will order specific
tests. When education is given and the “why?” is answered, RNs are more likely to
remember the education and recognize signs and symptoms in a patient. By the
participants completing the pretest and posttest, the doctoral student will be able to
measure what the RNs learned from the educational material presented.
DNP Essentials
The American Association of Colleges of Nursing (AACN)(2006) recognizes the
practice-focused DNP. The DNP is a terminal degree with a focus on the discipline of
nursing practice. The AACN (2006) has comprised eight curricular and elements and
competencies that need to be incorporated in all programs conferring the Doctor of
Nursing Practice degree. The doctoral student can include four of these essential elements
in the study:
•

Essential I- Scientific Underpinnings for Practice
o Addresses scientific knowledge concurrent with the complexity of practice

•

Essential II- Organizational and Systems Leadership for Quality Improvement
and Systems Thinking
o Quality improvement project related to sustaining changes at the
organization and policy level

•

Essentials III: Clinical Scholarship and Analytical Methods for Evidencebased Practice
10

o Integrates knowledge from diverse disciplines to apply to nursing practice
•

Essentials IV: Information Systems/Technology and Patient Care Technology
for the Improvement and Transformation of Health Care
o Uses technology to obtain patient data and configure results

•

Essentials VII: Clinical Prevention and Population Health for Improving the
Nation’s Health
o Discusses a health problem that is population-specific
Summary

Little research has been done regarding the RN’s knowledge about pre-eclampsia
and regular practices with patients presenting with pre-eclampsia in a hospital setting.
The doctoral student is suggesting an increase of knowledge at the RN’s level will help
reduce maternal and infant mortality. A pre-eclampsia educational video will be offered
to the RNs in conjunction with the pre-test and post-test.
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CHAPTER II - METHODS
Context
Little research has been done regarding the RN's knowledge about pre-eclampsia
and regular practices with patients presenting with pre-eclampsia in a hospital setting.
The doctoral student was suggesting an increase of knowledge at the RNs’ level would
help reduce maternal and infant mortality. A pre-eclampsia educational video was offered
to the RNs in conjunction with the pretest and posttest.
Interventions
A retrospective chart review was performed 6-months before the beginning of the
study to determine the times between when the patient that presents with symptoms of
pre-eclampsia enters the WUC to when they received treatment. Timeliness is essential
for the treatment of pre-eclampsia. The faster a diagnosis is determined, and treatment is
given, the better outcome is for the mother and the baby. Performing a chart review
before the education was given gave the doctoral student a baseline for the average time
that the unit was first treating patients that present with pre-eclampsia. For the study,
fliers were dispersed in the nursing breakroom and on the back of employee bathroom
doors about the study being conducted. Information was given about the research and QR
codes were listed for RNs interested in participating in the study voluntarily. Three QR
codes on the page: one for the consent and the pretest, the second for the education about
pre-eclampsia, and the third for the posttest. Qualtrics were used to access the consent,
pretest, and posttest. The educational video was uploaded onto YouTube for the viewer.
Each section of the study had its QR code and the participants could take them when they
had time. If the participant was needing to do the pretest and then on her next break,
12

watch the educational video and take the posttest, that was an option. If the participant
could do all three sections at once, that was allowed as well. Fliers were placed on the
walls as well as copies on the breakroom table that the RNs could take home with them
so that they had the QR codes available with them when they have the time to complete
the sections of the study. The pretest contained 13 questions with the first four
comprising of demographic information of the participant. The educational video was
uploaded to YouTube and pertained to the pathophysiology of pre-eclampsia, signs, and
symptoms the RN will look for, lab work that will be ordered, and information on
medication and the protocol for treating pre-eclampsia, the video could have been
watched more than one time. The posttest had the same questions as the pre-test,
including the first four demographic questions. For each test, the participant put in the
first four numbers of their birthdate for the tests to be evaluated evenly. The participants
were instructed that the first two digits would be their month and the last four digits
would be their day of birth, for example, if the participants birthday is August 4 their
code number will be 0804. That way the participant would know and remember their
code, but the doctoral student did not know who the participant was. The pretest and
posttest took about five to ten minutes to complete, and the educational video took about
10 minutes to watch. A retrospective study was then be performed one month after the
conduction of the study to monitor the times between when the patient with preeclampsia symptoms entered the WUC and when the received treatment to see if the
times had improved when compared to the chart reviews performed before the
interventions were started. If the times had improved, it shows that educating RNs on
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signs and symptoms and the dangers of the effects of pre-eclampsia on a woman’s body
will help the women receive treatment faster and therefore, have a better birth outcome.
In the year 2020, COVID-19 became a health concern for people worldwide.
Precautions were made to help keep the public safe. This study was done during the
COVID-19 pandemic and precautions were incorporated to keep the doctoral student and
participants safe. No personal contact was made between the doctoral student or the
participants. When placing fliers in the nurse’s breakroom, a face mask was worn by the
doctoral student. All educational material was conducted online for the current study due
to the pandemic restrictions.
Study of Interventions
The purpose of the project was to improve identification and responsiveness to
patients presenting with pre-eclampsia symptoms. A retrospective chart review before
and after the pre-and post-test for the RNs determined the impact of the education given
to the RNs on the women’s urgent care center. The retrospective chart review was to get
a baseline time for when the patients received care because timing is an especially
important aspect in caring for patients with pre-eclampsia. The purpose of the posttest
was to assess if the RNs learned anything from the video. The questions and answers
were found throughout the educational video. The education to the RNs was not only
about the signs and symptoms and hazards of pre-eclampsia but also teaching the RNs the
protocol of when the nurse should administer medications to women who present with
these signs and symptoms of pre-eclampsia. The education overall would help the RN to
understand more of the importance of monitoring the patient’s BP, communicating with
the provider, and expecting when and how much medication to give the patient. The
14

retrospective chart review after the post-test was to determine if the education helped the
patients receive treatment sooner. If the times decrease from when the patient receives
care in the chart reviews after the intervention, then the educational video helped the RNs
assess and acknowledge the patient's diagnosis sooner than before.
Population of Interest
Purposeful sampling took place from the coordinated hospital for the current DNP
project. The doctoral student used RNs currently employed by WUC in a central
Mississippi hospital with 722 beds. The RNs were employed as full-time, part-time, or
per diem, but any RN in orientation will be excluded from this study. These RNs are
chosen due to their clinical expertise and the population they served. The RNs were the
first providers the patients see when they go to the hospital. These RNs assessed, and the
providers determined if the women needed to be admitted to the hospital or if they could
be treated in the women’s urgent care center and then be able to go home.
Measures
Performing a pretest and posttest was a way of measuring the amount of
education learned by the RNs from the educational video. Conducting a pretest and
posttest was one of the best ways in evaluating interventions used for the type of research
being used (Alessandri et al., 2017). Several factors could hinder the results of these tests:
participants' poor level of monitoring of taking an assessment and the inability for the
participant to complete all three of the interventions. In the pretest and post-test, different
types of questions were asked. The doctoral student included multiple-choice, true or
false, and select all that apply. Both the pretest and posttest have 13 questions and
answers on the evaluation. The first four questions are demographic questions asking
15

how long the participant has been an RN, how long the RN had worked in a women’s
area, age, and educational level. By asking the same questions on both the pretest and
posttest, ensures test-retest reliability. “Test-retest reliability involves administering the
same measure to the same group of test-takers under the same conditions on two different
occasions and correlating the scores” (Deniz & Alsaffar, 2013, p. 498).
Analysis
This project determined the quantitative measurement of the education the RNs
on the WUC learned from the educational video with this quasi-experiment design. The
results of the pre-test and post-test were entered into REDCap by the doctoral student to
keep safe and secure and then be able to be downloaded into Excel for easier data
analysis. The first four questions were not included in the analysis due to the
demographic nature of the questions.
The doctoral student also determined the times before the intervention was
conducted on the amount of time a patient presented to the WUC to when the patient
received treatment. The average times were calculated in Excel [=AVERAGE()] and the
difference determined if the times were better (a decrease in times) after the intervention
or worse (an increase in times).
Ethical Considerations
A letter of support from the facility and approval of the Institutional Review
Board (IRB) of The University of Southern Mississippi (USM) (Protocol #-21-272) and
the IRB board from The University of Mississippi Medical Center (UMMC) (protocol
#2020V0373) were obtained before any implementations were initiated. Any participants
related to the study contributed by volunteer status. No participants were coerced or
16

persuaded into participating. All information was confidential, no identifying information
was given during the study. The surveys were secured and only the doctoral student had
access to the records of the results of the survey. Qualtrics had survey protection that was
enabled for anonymity. The pre and post-tests did have demographic information and had
an assigned number of the participant's birth month and day (August 4 will be 0804), but
this was not enough information to give away any participant's identity. Information from
Qualtrics was also be uploaded into REDCap along with the times collected from the
retrospective chart reviews. Consents were electronically signed before the pretest and
gave consent for the pretest, education, and posttest. The participant was allowed to drop
out without any drawbacks from the surveyor anytime during the pretest, educational
material, or the posttest.
Ethical considerations will also be taken with obtaining information from chart
reviews. The doctoral student did not collect any protected health information for this
study. Only the diagnosis and the time the patient presented to the women’s urgent care
and the time treatment was given. The information will be logged into the primary
doctoral student’s computer which was password protected and put into REDCap for 6
months after the requirements for graduation are complete.
Project Timeline
The project timeline will be 2 months. Two weeks for the fliers with the QR codes
to be posted in the bathrooms and the nurse's breakroom for the RNs to participate in the
research. The doctoral student will be performing the retrospective search and analysis of
the chart reviews during the assigned time. The doctoral student will then wait 1 month
and perform another retrospective chart review to determine if the times for the cases
17

have decreased. The doctoral student is allowed a week for the post-intervention
retrospective chart review.
Summary
Although there is no definitive test to know who will develop pre-eclampsia,
knowledge is available to help those women who do develop pre-eclampsia. Educating
RNs and providers on the safest and best way to control a women’s BP and how to test
for pre-eclampsia is a crucial step in helping a woman and her baby if she should develop
pre-eclampsia. Understanding the pathophysiology of what is happening in the body will
help the RN remember what to expect for orders and signs and symptoms to look for in
the woman.
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CHAPTER III – RESULTS
Results
The goal of this project was to decrease mortality rates in pre-eclampsia patients
and their babies by giving the RN’s education and assessing their retention of the
information and seeing if the RNs put the education into practice. The education gave the
RNs information about who is at risk for pre-eclampsia, how it might be developed in the
growing placenta, how and what organs are affected by this disorder, and reviewing the
protocol of treatment. This project had two parts, chart reviews and the intervention that
included the education for the nurses.
A retrospective chart review was conducted six months before the beginning of
the planned intervention of the pre-test, educational video, and post-test. The doctoral
student recorded the times from when a patient presents to the WUC to the time of
treatment for increased BP (systolic 160 or higher and/or diastolic 110 or higher). While
looking at the chart reviews, the doctoral student noticed not all women who received
hypertension treatment, presented with symptoms, some women came in for other
concerns and upon taking vital signs, the women’s BP was elevated and needed
treatment. Taking the women who presented to the unit without known BP issues into
consideration, the times are not a reliable source of measurement to see if the
interventions were successful. The average time discovered between entering the clinic
and receiving treatment was 58 minutes. Since some women did not have an elevated BP
at the beginning of the visit at WUC, the better way to measure would be to know the
difference between the time of the elevated BP and the time of treatment. Calculating this
information showed the average time from elevated BP to treatment was 7.6 minutes.
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This unit is very well equipped for high-risk patients and many times if they are warned
by the provider sending a patient over to be monitored, the RN will go ahead and insert
an IV when the patient is admitted to keeping the times down for if they do have an
elevated BP and need treatment.
The doctoral student first looked at the Unit Report Algorithm to get a baseline
for the compliance rate for the WUC. The retrospective chart review revealed a 37.44%
compliance with giving the patient any hypertension medication with an elevated BP.
Looking at the Unit Report Algorithm, the system would record when the patient was put
into the system on WUC, the times of an increased BP and the result of the BP
measurement, and the time and medication that was given. So if a patient had 4 elevated
blood pressures (systolic pressure at or above 160mmHg and/or diastolic pressure at or
above 110mmHg) those four would be put in the report along with the time the BP was
taken. If the same patient was treated with medication, it also shows what medication and
time that the medication was given. The Unit Report Algorithm did not take some factors
into account. Some patients would have a randomly elevated BP and the nurse would
assess and note an inaccurate BP reading due to an inaccurate BP cuff because too small
a cuff can produce a high BP reading, or the patient was moving when the BP was being
taken. These instances, of course, will cause a falsely elevated BP and must be retaken.
Other times, the patient was being taken up to be admitted to Labor and Delivery, and the
medication was given on that floor. The protocol for elevated BP that WUC follows,
states that after the medication is given for increased BP, to wait 20 minutes before
obtaining another BP reading. On more than a couple of patients, the BP was taken
before the 20-minute timeframe. After the 20-minute time limit was reached, the patient’s
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BP was out of the extreme range and fallen below 160/110mmHg. With all the
calculations taken correctly by the doctoral student, the compliance rating for the WUC
before interventions were 69%.
The results of the pre-test and post-test are inconclusive. The doctoral student
received 4 participants that completed the pre-test, the educational video, and the posttest. One participant answered all the questions correctly on the pre-test and post-test, one
participant answered the same questions wrong on both the pre-test and post-test thus
getting them the same grade, another made a worse grade on the post-test than the pretest, and one improved their grade on the post-test than the pre-test after watching the
educational video. The results showed 100% of the participants were over the age of 30
and 75% of the participants had 10+ years of experience in women’s health as an RN,
either in Labor and Delivery, working on WUC, or in postpartum.
Table 1
Pre-test and Post-test Correct Answer Percentages
Pretest Scores
Correct

Posttest Scores

Incorrect

Correct

Question

N

Percent

N

Percent

N

Percent

Q6

2

50%

2

50%

3

Q7

4

100%

0

0%

Q8

4

100%

0

Q9

4

100%

Q10

4

Q11

3

Incorrect
N

Percent

75%

1

25%

4

100%

0

0%

0%

4

100%

0

0%

0

0%

4

100%

0

0%

100%

0

0%

4

100%

0

0%

75%

1

25%

3

75%

1

25%
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Table continued
Q12

1

25%

3

75%

4

100%

0

0%

Q13

3

75%

1

25%

3

75%

1

25%

Q14

4

100%

0

0%

4

100%

0

0%

*Actual questions are shown in appendix B

The WUC is accustomed to seeing high risk pregnancies and are well equipped
for emergencies and have done much education for pre-eclampsia. The RNs who work on
this unit are mostly well seasoned Labor and Delivery nurses who have dealt with these
high-risk patients and how to treat their ailments, which is probably why there was not a
huge change in compliance. The tools used for the intervention were created by the
doctoral student due to no tools available for this situation. If these tools were
implemented at a less critical hospital and unit, they might have shown a different
outcome than inconclusive.
Table 2
Results
Compliance
before
intervention

Compliance
after
intervention

69%

50%

Times from
entering the unit
to treatment
before
intervention
58min

Times from
entering the unit
to treatment
after the
intervention
77 min

Times from
increased
BP before
intervention

Times from
increased
BP after
intervention

7.6min

9.75min

The post retrospective chart review was completed for the month after the
intervention was finished. Due to the restricted time frame, not many encounters of
elevated BPs were presented when compared to the six months before the before
retrospective chart review. The compliance rate for this month was 50%. Looking at the
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charts, several patients that had elevated BP readings and were taken to be admitted to
labor and delivery before medication was administered. When comparing the two
compliance rates, the compliance got worse after the interventions. The average time
from entering the WUC and receiving treatment increased as well, increasing to
77minutes. The times in between when the patient had a high BP reading and when she
received treatment also increased to 9.75minutes.
Discussion
While pre-eclampsia is a very serious diagnosis, the results of this project were
not reassuring in helping decrease the times that women received treatment. The results
displayed that the educational intervention did not help with the times between when the
women presented to the unit with pre-eclampsia symptoms and when the patient received
treatment, nor did the intervention help with compliance in the protocol being
implemented on the WUC unit for when to administer medication after increased BP
readings, which caused a gap in nursing practice and when giving the treatment needed.
Looking through the charts, the women who were being transferred to labor and delivery
for preeclampsia should be treated before being sent to the next unit to help reduce
inequalities in their care.
Considering the results of the project, certain situations could have changed the
results to where at least the compliance rates could have increased. First, there were not
enough participants to make a difference. Only 4 participants out of a total of 18
completed the pre-test, educational video, and post-test. Secondly, more time was needed
after the intervention to do more chart reviews over several months. The best and most
accurate way to measure compliance and times would have been to monitor at the same
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time next year. The summer months have been shown to have more women present with
symptoms of pre-eclampsia and high BP. Performing chart reviews over the same six
months would be more reliable due to the same environmental setting due to the same
time of year. Third, this doctoral project was created to verify if more education for
nurses over pre-eclampsia would help in lower times for treatment. At the facility in
which the project was performed, the times from the time of elevated BP to the time of
treatment were already satisfactory. Implementing this education at another hospital
whose times were not adequate, might have achieved better outcomes. If these three
challenges were faced and resolved, the outcomes might be in favor of improving times
for the patients.
Looking at the times of treatment from when the patient had a high BP reading
and when they received treatment, were good and reasonable from the beginning. This is
due to the high critical care that the staff is accustomed to and the years of experienced
nurses on the unit. The range of times the patients received treatment on WUC was from
1 minute to 15 minutes, with the higher times due to not being able to obtain an
intravenous line. Implementing this project at a different hospital, perhaps a hospital that
does not treat many pre-eclamptic patients, the times to treatment may have improved.
The beginning average time of 7.6 minutes from increased BP to treatment is an
exceptionally good average for as many patients that they treat, which is approximately
10,000 patients a year.
Although the results showed an increase in times of treatment and the compliance
rating decreased, the project unveiled some areas that need improvement on the unit. The
nurses need to always treat patients for hypertension before transferring to another floor
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unless a true emergency develops, and the risk outweighs the benefit in treatment.
Another aspect that needs addressing is some areas of charting. Looking at the Unit
Report Algorithm which showed the times the patient would have elevated blood
pressure, some of the patients would have an elevated BP, the nurse would take another
BP within five-10 minutes and the BP would be below the parameters of getting
treatment, but some of the nurses are not documenting if there was a reason for the
increased blood pressure. When the patient has elevated blood pressure, the nurses will
not give hypertensive medication, but not documenting the reason for the falsely elevated
BP is another gap in the care of the patient due to not communicating with the providers
and other staff why the patient had a false BP reading or what was happening in the room
at the time of the BP reading.
The results of the project were not expected when planning and implementation
began. The outcomes were expected to decrease the times between presenting to the
WUC and treatment for the patient. The nurses on WUC are experienced in this area and
see many patients throughout the year with pre-eclampsia which keeps them familiar with
the protocol and treatment plans. Although the compliance rates decreased and the times
of treatment increased, helpful information was learned to help increase compliance rates
for WUC such as treating the patient when they have an increased blood pressure before
moving the patient to another unit. Addressing pre-eclampsia for yearly competencies is
important in any labor and delivery unit. Knowing the protocols for treatment, helps
nurses feel more comfortable with these patients. Limited information is available about
how and what type of education for nurses and/or providers can help decrease mortality
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rates in women with pre-eclampsia. This project is a good preliminary step that needs
further investigation.
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APPENDIX A – Pre-eclampsia Treatment Protocol

(University of Mississippi Medical Center, 2020)
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APPENDIX B - Pre- and Post-test Questions
How long have you been a nurse? (select one)
•

0-5 years

•

5-10 years

•

10-15 years

•

15-20 years

•

more than 20 years

How long have you worked in a women's care setting (i.e.- labor and delivery,
postpartum, women's urgent care)?
•

0-5 years

•

5-10 years

•

10-15 years

•

15-20 years

•

more than 15 years

What is your age?
•

20-30 years old

•

30-40 years old

•

40-50 years old

•

50-60 years old

•

60+ years old

•

prefer not to answer

What is your education level?
•

ADN

•

BSN

•

MSN

•

Other
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Some high-risk factors for pre-eclampsia are: (select all that apply)
•

chronic renal disease

•

diabetes

•

vascular disease

•

chronic hypertension

•

women of young age

Magnesium Sulfate is used to help reduce blood pressure in severe hypertension.
•

true

•

false

Pre-eclampsia is "cured" by (select one)
•

labetalol

•

magnesium sulfate

•

delivery of baby

•

there is no cure

What is considered severe blood pressure? (select one)
•

154/94

•

161/112

•

159/100

After giving labetalol 20mg IV for severe hypertension, how long should you wait to
repeat the blood pressure? (select one)
•

5 minutes

•

10 minutes

•

20 minutes

What is the cause of pre-eclampsia? (select one)
•

the placenta

•

the liver
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•

it's just something that happens

What lab work would be anticipated for the doctor to order for someone with symptoms
of pre-eclampsia? (select all that apply)
•

CBC

•

CMP

•

Uric Acid

•

CRP

•

TSH

•

UA

What organs can be affected by pre-eclampsia? (select one)
•

kidney, liver, brain

•

kidney, lungs, heart

•

thyroid, liver, pancreas

What are some medications to help in the reduction of blood pressure? (select one)
•

labetalol, nifedipine, hydralazine

•

labetalol, magnesium, hydralazine

•

metoprolol, Lasix, hydralazine
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APPENDIX C - Transcript for Educational Video
Hello! My name is Amber and I am going to review pre-eclampsia with you today
and update you on the protocols for treatment.
Let’s first talk about patients that could present to your unit with higher risk
factors than others. It is difficult to predict who will experience preeclampsia during their
pregnancy due to the unknown nature of the syndrome, but certain risk factors involved
could increase a woman’s chance. Patients who have chronic hypertension, are of
advanced age, have chronic renal disease, are obese, have vascular disease, of young age
(less than 17 years old), have a personal or family history of pre-eclampsia, have
diabetes, used in-vitro fertilization to become pregnant, nulliparity, multifetal pregnancy,
or have lupus are some that have a higher risk for developing pre-eclampsia than other
patients.
The exact etiology of pre-eclampsia is unknown but let us talk about what could
be possible causes of pre-eclampsia. Studies are suggesting that the placenta can be the
cause of pre-eclampsia. Genetic abnormalities, poor uterus perfusion, and an abnormally
functioning placenta are all probable causes of pre-eclampsia.
So, what exactly is happening to the body during pre-eclampsia? We have 3 key
factors in pre-eclampsia: the spiral arteries, the placenta, and the mother's body
(specifically the endothelial cells). The spiral arteries are found in the uterus and they
play a big role in supporting the pregnancy. The trophoblasts that bed into the uterus and
need good blood flow to the placenta through the spiral arteries. At 20 weeks gestation,
these vessels will widen for more blood flow to nourish the baby. In pre-eclampsia, the
vessels do not widen like they are supposed to and therefore cause vasoconstriction.
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Vasoconstriction of the vessels in the placenta and the mothers’ body will cause
the blood pressure to rise. Picture a garden hose and you put your thumb over the opening
and the pressure of the water increases and comes out with more force, this is what is
happening inside of the vessels with increased blood pressure.
With decreased blood flow to the placenta and it will become ischemic and the
baby will not be able to grow and develop properly. When the placenta experiences
ischemia, it will release toxic substances into the endothelial cells in the mothers’ body
and become damaged.
Endothelial cells line the inside of the blood vessels throughout the whole body,
they line the organs like the kidneys, brain, and liver. They control the tone of the blood
vessel which causes vasoconstriction and causes high blood pressure in the patient. These
endothelial cells that are damaged also allow fluid to leak due to less permeability of the
blood vessels. The kidneys, particularly the glomerulus, are what filter out your blood,
usually, they do not let large molecules. Protein is one of the large molecules that is
allowed to leak out of the vessels when the endothelial cells are damaged. Protein
regulates oncotic pressure and when protein is being leaked out of the vessels, water is
going to follow. So protein is going to leave the blood and it is going to go into the urine.
The kidneys are not functioning as they should, vasospasms are happening and
decreasing the profusion to the kidneys. Water is leaving the blood throughout the body
and so it is letting the blood volume drop. When blood volume drops, blood flow cannot
effectively reach organs in the body. So the kidneys are not functioning as they should.
Kidneys usually can regulate uric acid and are no longer able to do this, so uric acid is
going to increase which is a waste product. Creatinine levels are going to rise as well and
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urinary output is going to decrease because the kidneys are not functioning as they
should.
Edema is going to happen because of the permeability problem in the vessels and
water leaking into the interstitial tissues. You will notice puffiness in the face and around
the eyes and edema in the extremities.
The lungs can be affected because fluid is getting trapped in her lungs causing
pulmonary edema and so she will complain of shortness of breath. Edema can also
happen in the brain causing cerebral edema. Remember there are endothelial cells in the
head that are also leaking. This is where symptoms can be severe and start turning into
eclampsia. When there is swelling in the brain, you will see the CNS symptoms of severe
headaches, vision changes, or hyperreflexia. We always want to be checking those deep
tendon reflexes and checking for clonus in the ankles. When they are experiencing these
symptoms, they are at high risk for convulsion episodes.
The liver is also going to be damaged, so the liver enzymes are going to increase,
so you are wanting to look at the ALT and the AST. The patient could complain of upper
right quadrant pain.
Diagnosing a patient with pre-eclampsia comes down to lab work and objective
information found in the physical assessment. The patient must have increased blood
pressure, protein in the urine, and signs of organ injury of either the brain, kidneys, or
liver. The patient must be over 20 weeks to be diagnosed with pre-eclampsia.
Accurate blood pressure readings are important in treatment. Make sure that the
right size cuff is on the patient (too small with give an artificially high number and too
large of the cuff will give an artificially low number). The patient should be supine in a
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semi-reclining position or a sitting position without their legs crossed. There need to be at
least 2 separate readings of increased blood pressure or diastolic number above 90 and
systolic above 140.
Vitamin C, vitamin D, or calcium are not effective at stopping the development of
adverse effects of pre-eclampsia. The only way to treat preeclampsia is to deliver the
baby.
Immediate-release oral nifedipine may be given if IV access is not available.
Magnesium sulfate is not used as an antihypertensive agent but used for seizure
prophylaxis. Be prepared to give Celestone to your patient if the gestational age is under
34 weeks.
Severe hypertension would be systolic pressure equal to or above 160 mmHg and
diastolic equal to or above 110 mmHg.
The degree of systolic hypertension may be the most important predictor of
cerebral injury and infarction in the mother.
Administration of IV labetalol for severe hypertension guidelines is to give 20mg
of IV labetalol and check blood pressure after 20 minutes. If blood pressure is still
elevated with systolic at or above 160 and/or diastolic at or above 110, give 40mg of
labetalol IV. If blood pressure is still elevated after 20 minutes, give 80mg of labetalol
IV. The total amount of labetalol given in 24 hours should not exceed 300mg. If blood
pressure is still elevated after giving 80mg of labetalol IV, give 10mg of hydralazine IV.
If you start the protocol by giving 10mg hydralazine IV, check the blood pressure after 20
minutes. If blood pressure is still equal to or above 160/110 give another 10mg
hydralazine IV. Wait another 20 minutes and if the blood pressure is still out of range,
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give 20mg of hydralazine IV. If your patient is still experiencing severe hypertension,
give 40mg of labetalol IV. If you do not have any IV access and you are needing to give
your patient immediate care for their severe hypertension, immediate-release 10mg
nifedipine should be given. Recheck the blood pressure after 20 minutes and if the
systolic or the diastolic pressure is out of range give 20mg of immediate-release
nifedipine. Recheck the patient's blood pressure after 20 minutes and if still elevated
above 160 or 110, give another 20mg of immediate-release nifedipine. You need to
attempt to obtain IV access during this time and if you recheck the blood pressure after
20 minutes after giving the second dose of 20mg of nifedipine, give 20 mg of labetalol
IV. Once BP is below the threshold, continue to monitor BP every 20 minutes for an hour
and if the BP is still below threshold, monitor every 30 minutes for one hour, and then
hourly.
Start with the labetalol protocol if possible because the antepartum maximum
dose of hydralazine in 24 hours is only 20mg. There is no maximum amount for those not
pregnant. Do not give labetalol to asthmatics. Magnesium should be given with caution in
patients with acute or chronic renal disease. When giving magnesium for seizure
prophylaxis in antepartum patients, give a 6g loading dose and 2g/hr. continuously. If
giving magnesium to postpartum patients, give a 4g loading dose and then 2g.hr.
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APPENDIX D - Consent to Participate in Study
The University of Mississippi Medical Center
Study Title: Pre-Eclampsia Evidence-Based Registered Nurse Staff Education Project
Principal Investigator: Amber Vetter
________________________________________________________________________
_____
Introduction
You are being invited to be in this experimental research study because you are a key
player in the treatment of women with pre-eclampsia that present to the hospital. Please
ask us about anything in this document or that we tell you that you do not understand.

Purpose
We are doing this study to learn if educating nurses about the signs and symptoms of preeclampsia and the dangers to the mother and baby, would make a difference in treating
the mother quicker.
Procedures
If you agree to participate in this study, you will be asked to answer a few questions
about pre-eclampsia, watch a short 15-minute educational video on pre-eclampsia, and
then answer a few questions about the information that you might have learned from the
educational video. The entire process should take around 15-20 minutes.
Benefits
You will not receive a direct benefit from being in this research study. We hope to learn
information that may help others in the future.
Costs
There will not be any costs to you if you participate in this study.
Compensation
You will not be paid for participating in this study. Voluntary Participation
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Your participation is voluntary. If you decide not to participate in this study, you will not
suffer a penalty or loss of benefits to which you are otherwise entitled.

Withdrawal
You may choose to stop your participation in this study at any time. If you decide to
withdraw the information already collected about you may still be used in this study but
additional information will not be collected. Your decision to stop your participation will
not affect the quality of medical care you receive at the University of Mississippi Medical
Center.
Confidentiality
Your answers to the questions will be stored initially with Qualtrics in a passwordprotected electronic format via The University of Southern Mississippi. Data will later be
downloaded and stored on a computer that will be password protected. We will not
collect any protected health information about you for this study. Confidentiality will be
maintained. All data will be deleted six months after all graduation requirements have
been met.
Protected Health Information
Protected health information is any personal health information through which you can be
identified. Your name and signature will be on this document, but we will not collect any
other identifiable health information for this study. By signing this consent document,
you authorize Amber Vetter and her study staff to collect this information and use your
records as necessary for this study.
The information collected for this study will be kept until the study is complete and may
be combined with information collected through other research studies or used in other
studies, but no information will identify you. While this study is ongoing you may not
have access to the research information, but you may request it after the research is
completed.

This authorization has no expiration date. If you do not sign this consent document, you
will not be allowed to participate in this study.

Number of Participants
We expect 18 participants to enroll in this study here.
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Questions
If you have questions about this study or need to report any problems please call Amber
Vetter at 575-520-0853.
You may discuss your rights as a research participant with the Chairman of the
University of Mississippi Medical Center’s Institutional Review Board, 2500 North State
Street, Jackson, Mississippi 39216; telephone, 601 984-2815; facsimile, 601 984-2961.
The Institutional Review Board is a group of people not involved with this study who
have reviewed the study to protect your rights.
You will be given a copy of this consent document for your records.
Statement of Participation
I have been told about this study and the possible risks and benefits. My participation is
voluntary and I may withdraw at any time without any penalty or loss of benefits to
which I am entitled, including medical care at the University of Mississippi Medical
Center.
Electronic Consent
By clicking the button below, you acknowledge:
•
•
•
•
•

You have read and agree with the above information.
Your participation in the study is voluntary.
You are 18 years of age or older.
You are a full-time, part-time, or PRN registered nurse for Women's Urgent Care
of UMMC.
You are aware that you may choose to stop your participation at any time for any
reason.
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